Literature DB >> 2759136

Tissue distribution and excretion of radioactively labelled compounds in the Wistar rat after administration of [N-methyl-14C]-erythromycin A.

I O Kibwage1, M Michiels, R Hendriks, T Cachet, A Verbruggen, J Hoogmartens, H Vanderhaeghe.   

Abstract

Tissue distribution and excretion of radioactively labelled compounds was studied in the Wistar rat after i.v. administration of [N-methyl-14C]-erythromycin A. Whole-body autoradiography and liquid scintillation counting was used to investigate the tissue localization of radioactivity in pregnant and non-pregnant rats. Tissue levels were maximal within 20 min, except for lachrymal glands, thymus and brain. Large amounts of radioactively labelled compounds, partly originating from active secretion, were present in the small intestine and caecum. Marked concentration of radioactively labelled compounds was also observed in the liver, spleen, lachrymal and salivary glands, lymph nodes, mammary glands, skin, bone marrow, and, to a lesser extent, in the lung, kidney and skeletal muscle. During six hours of experimental follow-up, plasma levels remained lower than corresponding tissue levels. At 1 h the radioactivity in fetuses was about three times lower than that in maternal blood. Within 48 h, more than 90% of the administered radioactivity was excreted. The amounts of radioactivity recovered in urine, faeces and expired air were about 19%, 48% and 24% respectively. After 48 h, 8% of the administered radioactivity was found in the carcass.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759136     DOI: 10.1007/BF03190835

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  The excretory products of N-methyl-C14-erythromycin in rats.

Authors:  C C LEE; R C ANDERSON; K K CHEN
Journal:  J Pharmacol Exp Ther       Date:  1956-07       Impact factor: 4.030

2.  Distribution and excretion of radioactivity in rats receiving N-methyl-C14-erythromycin.

Authors:  C C LEE; R C ANDERSON; K K CHEN
Journal:  J Pharmacol Exp Ther       Date:  1956-07       Impact factor: 4.030

3.  Site of absorption of erythromycin in rats.

Authors:  C C LEE; R C ANDERSON; K K CHEN
Journal:  Antibiot Chemother (Northfield)       Date:  1954-09

4.  Tissue distribution of erythromycin in rats.

Authors:  C C LEE; R C ANDERSON; K K CHEN
Journal:  Antibiot Chemother (Northfield)       Date:  1953-09

5.  Antibiotics excretion in canine vaginal and urethral secretions.

Authors:  U Hoyme; A Baumueller; P O Madsen
Journal:  Invest Urol       Date:  1978-07

6.  Demethylation of erythromycins by rabbit tissues in vitro.

Authors:  J C Mao; P L Tardrew
Journal:  Biochem Pharmacol       Date:  1965-07       Impact factor: 5.858

Review 7.  Erythromycin.

Authors:  M J Gribble; A W Chow
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

8.  Intestinal secretion of erythromycin base.

Authors:  D R Holland; J F Quay
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

9.  Whole body tissue distribution of [14C]-erythromycin in the guinea pig. An autoradiographic study.

Authors:  G A Dette; H Knothe; H M Kellner
Journal:  Arzneimittelforschung       Date:  1987-05

10.  Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives.

Authors:  I O Kibwage; J Hoogmartens; E Roets; H Vanderhaeghe; L Verbist; M Dubost; C Pascal; P Petitjean; G Levol
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

  10 in total
  1 in total

1.  Orally administered erythromycin in rainbow trout (Oncorhynchus mykiss): residues in edible tissues and withdrawal time.

Authors:  Annarita Esposito; Laura Fabrizi; Dario Lucchetti; Luigi Marvasi; Ettore Coni; Emilio Guandalini
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.